Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar
AbstractHepatitis C virus [HCV] infection is a major public health problem in the Middle East. A database of 400 patients with chronic HCV in Qatar was retrospectively analysed: 242 patients underwent antiviral treatment, of whom 212 [87.6%] were naive to treatment. The response to treatment and the predictors of response were studied. The largest group of patients were of Egyptian origin. The rate of sustained virological response [SVR] varied significantly between patients with HCV genotypes 2 or 3 [79.6%] and genotype 1 [45.6%] and 4 [the predominant genotype] [51.0%]. Multivariate analysis showed that the independent predictors of SVR were age < 45 years, infection with genotypes 2 or 3, low fibrosis score on liver biopsy and naive treatment status
John, A.K., Al Kaabi, S., John, A., Singh, R. & Derbala, M. (2010). Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar. EMHJ - Eastern Mediterranean Health Journal, 16 (11), 1121-1127, 2010 http://www.who.int/iris/handle/10665/118039
JournalEMHJ - Eastern Mediterranean Health Journal, 16 (11), 1121-1127, 2010
MetadataShow full item record
Showing items related by title and MeSH subject.
Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients Kishk, R.; Aboul Atta, H.; Ragheb, M.; Kamel, M.; Metwally, L.; Nemr, N. (2014)Chronic hepatitis C virus [HCV]infection combined with occult hepatitis B virus [HBV]infection has been associated with increased risk of hepatitis, cirrhosis and hepatocellular carcinoma.This study aimed to determine the prevalence of occult HBV infection among Egyptian chronic HCV patients, the genotype and occurrence of surface gene mutations of HBV and the impact of co-infection on early response to treatment.The study enrolled 162 chronic HCV patients from Ismailia Fever Hospital, Egypt, who were HBV surface antigen-negative.All patients ...
Progress reports on technical programmes : Health security and the Asia Pacific strategy for emerging diseases and public heath emergencies; noncommunicable diseases; tobacco-free initiative; mental health; tuberculosis; hepatitis; traditional medicine; gender and health Regional Committee for the Western Pacific, 068 (WPR/RC68/11, 2017)